Quantcast
Home > Quotes > HAIR

Restoration Robotics, Inc. Common Stock (HAIR) Quote & Summary Data

HAIR 
$0.662
*  
0.048
6.76%
Get HAIR Alerts
*Delayed - data as of Mar. 22, 2019  -  Find a broker to begin trading HAIR now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 0.662 / $ 0.71
Today's High / Low
$ 0.7084 / $ 0.66
Share Volume
720,965
50 Day Avg. Daily Volume
1,122,888
Previous Close
$ 0.71
52 Week High / Low
$ 7.88 / $ 0.352
Market Cap
26,987,762
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
720,965
50 Day Avg. Daily Volume:
1,122,888

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.87

Trading Range

The current last sale of $0.662 is 88.07% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 0.7084 $ 7.88
 Low: $ 0.66 $ 0.352

Company Description (as filed with the SEC)

We are a medical technology company developing and commercializing a robotic device, the ARTAS System, that assists physicians in performing many of the repetitive tasks that are a part of a follicular unit extraction surgery, or FUE, a type of hair restoration procedure. We believe the ARTAS System is the first and only physician-assisted robotic system that can identify and dissect hair follicular units directly from the scalp and create recipient implant sites. The ARTAS System includes the ARTAS Hair Studio application, an interactive three-dimensional patient consultation tool that enables a physician to create a simulated hair transplant model for use in patient consultations. We received clearance from the U.S. Food and Drug Administration, or FDA, in April 2011 to market the ARTAS System in the U.S., and we have sold the ARTAS System into 36 other countries. As of December 31, 2017, we have sold 94 ARTAS Systems in the U.S. and 159 internationally.  ... More ...  



Risk Grade

Where does HAIR fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 0.695
Open Date:
Mar. 22, 2019
Close Price:
$ 0.662
Close Date:
Mar. 22, 2019


Consensus Recommendation

Analyst Info